Latest Spotlights
Aston University AI project aims to make international health data sharing easier
Project to improve sharing data while complying with general data protection regulation (GDPR) guidelines Aston Institute of Photonic Technologies awarded almost £300k to work on ...
Georgia Southern receives $1.5M grant from U.S. Army medical research and development to enhance soldier performance and readiness
The Georgia Southern University Soldier Performance and Readiness (SPAR) program received a $1.5 million, two-year grant from the Department of Defense’s U.S. Army Medical ...
The CRISPR Dilemma: A Road To Saving Lives Riddled with Roadblocks
The New York Times recently published an Op-Ed by Dr. Fyodor Urnov unpacking the incredible advancement and possibilities of CRISPR gene editing technology on human ...
Researchers awarded £2 million to develop drugs to prevent epileptic seizures in children
• Three-year research project to develop new drug treatments for childhood epilepsy • Scientists will test new treatment on pieces of living brain tissue • The research is ...
Potential long-term treatment for asthma found - new research
New approach tackles one of the causes of asthma, not just its symptoms In treated mice, symptoms virtually disappeared within two weeks Further research needed ...
Cord blood awareness – let our experts help with coverage
July is Cord Blood Awareness Month. In the simplest of terms, cord blood is found in the blood vessels of the placenta and the umbilical ...
Big trouble for big pharma – let our expert explain
Things are sunny and bright for the usually family-friendly image of Johnson & Johnson. In fact, as more and more evidence and details are presented in ...
Accelerating the Development of Digital Cancer Diagnostics
Accelerating the development of new digital cancer diagnostics in the field of pathology is the aim of a new partnership between diagnostics pioneer LUMEA, Inc. ...
The Value of a Cure and Do All Americans Benefit from Medical Breakthroughs?
On February 28, 2017 policymakers, health officials, industry representatives and patient advocates were meeting in Washington to discuss the ‘value of a cure’ – the costs, the public ...